SIX Swiss Exchange

EQS-News: MPC Energy Solutions and Leclanché form strategic collaboration for utility-scale energy storage solutions

Retrieved on: 
Monday, December 20, 2021
COP26, Solution, Government, Electricity, Company, Trust, Ownership, Enel Green Power, Power purchase agreement, Environment, Industry, Wind, PPA, BESS, SIX Swiss Exchange, CEO, PV, Engineering, Green Power, Terminology, Heart, SWB, CO2, Partnership, EPC, Carbon, Renewable energy, Asphalt, Risk management, Saint Kitts, Basseterre Valley, MPC Energy Solutions, Leclanché, MPC ENERGY SOLUTIONS, LECLANCHé

Anil Srivastava, CEO at Leclanch, said: "We are excited to partner with MPC Energy Solutions for this landmark project in the Caribbean.

Key Points: 
  • Anil Srivastava, CEO at Leclanch, said: "We are excited to partner with MPC Energy Solutions for this landmark project in the Caribbean.
  • MPC Energy Solutions ("MPCES") is a global provider of sustainable energy and primarily focuses on low-carbon energy infrastructure, including solar and wind assets, and other hybrid and energy efficiency solutions.
  • More details at www.mpc-energysolutions.com
    Headquartered in Switzerland, Leclanch SA is a leading provider of high-quality energy storage solutions designed to accelerate our progress towards a clean energy future.
  • Leclanch is the only listed pure play energy storage company in the world, organised along three business units: stationary storage solutions, e-Transport solutions and specialty batteries systems.

EQS-News: Helvetia (CH) Swiss Property Fund posts strong result for the 2021 financial year

Retrieved on: 
Monday, December 20, 2021
EBIT, SIX Swiss Exchange, Income, COVID-19, CH, SXI, Investment, Real estate

The Helvetia (CH) Swiss Property Fund is reporting a very encouraging result for the second financial year.

Key Points: 
  • The Helvetia (CH) Swiss Property Fund is reporting a very encouraging result for the second financial year.
  • After transaction costs from the purchase of the initial portfolio of 29 properties impacted on the short first financial year (3.6.2020 to 30.9.2020), the 2021 financial year revealed the portfolio's strong earning power over the twelve-month period.
  • On the strength of the dominant residential component of 83% of the target rental income, the portfolio of the Helvetia (CH) Swiss Property Fund remained largely unscathed by the adverse effects of the COVID-19 pandemic in the second financial year too.
  • Low interest rates and stable income on the Swiss property market ensured the continuing appeal of the real estate asset class and strong demand for investment properties in 2021 as well.

EQS-News: Sonova nominates Julie Tay for election as a new member of the Board of Directors

Retrieved on: 
Monday, December 20, 2021
Person, Workforce, Solution, Bionics, Life, Securities Act of 1933, Breast implant, Unitron, Industry, Group, SIX Swiss Exchange, Hear the World Foundation, Hearing, Security, ISIN, Compliance, CHF, Regulation, Communication, Sonova

Should one or more of these risks or un-certainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected.

Key Points: 
  • Should one or more of these risks or un-certainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected.
  • Sonova, headquartered in Stfa, Switzerland, is a leading provider of innovative hearing care solutions.
  • Sonova shares (ticker symbol: SOON, Security no: 1254978, ISIN: CH0012549785) have been listed on the SIX Swiss Exchange since 1994.
  • The securities of Sonova have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the 'U.S.

EQS-News: Leclanché Completes Second Hybrid Energy Storage System with S4 Energy

Retrieved on: 
Monday, December 20, 2021
Solution, Electricity, Company, Science, BESS, SIX Swiss Exchange, EMS, Engineering, Terminology, Commercial director, EPC, Senior, Technology, EESS, Heart, TenneT, Renewable energy, Electric battery, Global Sales Law Project

- 10MW system to provide power to support frequency stabilization for TenneT, the Dutch Transmission System Operator

Key Points: 
  • - 10MW system to provide power to support frequency stabilization for TenneT, the Dutch Transmission System Operator
    - Leclanch served as engineering, procurement and construction (EPC) contractor
    - As in the Almelo Project, Leclanch integrated the battery energy storage system with S4 Energy's proprietary KINEXT flywheel storage system.
  • YVERDON-LES-BAINS, Switzerland and ROTTERDAM, Netherlands, 20th December, 2021 - Energy solution specialist S4 Energy , Rotterdam, The Netherlands, and Leclanch SA (SIX: LECN), one of the world's leading energy storage companies, have completed collaboration on a second highly innovative hybrid energy storage project in the northern portion of the country.
  • Leclanch served as the engineering, procurement and construction (EPC) contractor of the battery energy storage system (BESS).
  • S4 Energy has developed and holds various patents on energy storage technologies, including their uniquely efficient KINEXT storage units.

Addex Raises $10.0 Million in Equity Financing

Retrieved on: 
Friday, December 17, 2021
Therapy, L-DOPA, U.S. Securities and Exchange Commission, Form, PAM, Protein, Company, ADS, Clinical trial, Securities Act of 1933, Allosteric regulation, Epilepsy, PTSD, Glutamate receptor, Exercise, Sale, Nasdaq, Neurodegeneration, Act, United, LR, SIX Swiss Exchange, SEC, LLC, Dyskinesia, Drug Master File, American depositary receipt, 3rd Floor, ADX71149, Drug discovery, NAM, Glutamate (neurotransmitter), Park Avenue, ADSS, Janssen Pharmaceuticals, Security (finance), Glutamic acid, Warrant, Program, Blepharospasm, Regulation D, Dystonia, CHF, Lists of diseases

The Unregistered Pre-Funded Warrants have been funded to the amount of $6.49 with $0.01 payable on exercise.

Key Points: 
  • The Unregistered Pre-Funded Warrants have been funded to the amount of $6.49 with $0.01 payable on exercise.
  • The gross proceeds to Addex, before deducting placement agent fees and other offering expenses, will be $10.0 million.
  • Addex intends to use the net proceeds from this offering to advance its clinical and preclinical pipeline.
  • The closing of the offering is expected to occur on or aboutDecember 21, 2021, subject to the satisfaction of customary closing conditions.

Basilea announces FDA approval of Investigational New Drug application for novel oncology drug candidate BAL0891

Retrieved on: 
Friday, December 17, 2021
Investigational New Drug, Therapy, Food, FDA, Mycosis, Threonine, Cancer, MCI, IND, SIX Swiss Exchange, LR, Cell division, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Research, Patient, Chromosome segregation, PLK1, Infection, Mitosis, SAC, Isavuconazonium, Drug resistance, Chromosome, Trial of the century, Precision medicine, CHF, TTK, Communication, Pharmaceutical industry, Basel

The drug candidate offers the potential for a targeted development strategy in multiple cancers.

Key Points: 
  • The drug candidate offers the potential for a targeted development strategy in multiple cancers.
  • BAL0891 is differentiated through its unique kinase inhibition profile targeting both threonine tyrosine kinaseandpolo-like kinase 1.
  • We are looking forward to adding this potential first-in-class mitotic checkpoint inhibitor to our clinical oncology pipeline.
  • The IND approval triggers a milestone payment of CHF 1.85 million to the Dutch precision medicine company, NTRC, from which Basilea in-licensed BAL0891 in 2018.

ams OSRAM Announces the Sale of Its Horticulture Lighting Systems Business Fluence to Signify

Retrieved on: 
Monday, December 20, 2021
Semiconductor, Communications, Technology, Other Technology, Agriculture, Natural Resources, Public Relations, Investor Relations, LinkedIn, OSRAM, Solution, Light-emitting diode, Fast Company, Imagination, Intelligence, Life, Industry, Environment, Sunlight, Plant, LED, SIX Swiss Exchange, USD, High, Horticulture, CEO, Safety, Light, Quality of life, Efficiency, Facebook, Ams AG, AMS, Lighting, Twitter, ISIN, Technology, Health, Communication, Retail, Management, Renewable energy, 3D printing, Radiant exposure, Signify

Fluence and Signify are a strong match in complementary lighting expertise for the horticulture market.

Key Points: 
  • Fluence and Signify are a strong match in complementary lighting expertise for the horticulture market.
  • We look forward to continue providing Signify, and Fluence as part of Signify, leading technology for their business, explained Frans Scheper, Executive Vice President Opto Semiconductor Business.
  • ams OSRAM offers an industry-leading horticulture LED portfolio for professional top lighting, inter lighting and vertical farming applications.
  • The ams OSRAM Group, with its parent company ams AG (SIX: AMS), is a global leader in optical solutions.

Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation

Retrieved on: 
Monday, December 20, 2021
Biotechnology, Other Health, Health, Pharmaceutical, Medical Supplies, Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Food, FDA, Conditional sentence, Health, Vifor Pharma, Abbreviated New Drug Application, SIX Swiss Exchange, LR, Mylan, Anemia, ART, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Nephrology, Patient, Patent, Multimedia, ISIN, U.S. FDA, Fresenius Medical Care, Generic drug, Pharmaceutical industry, American, EU

We are pleased to have settled all outstanding patent litigations regarding Injectafer, commented Dr. Oliver P. Kronenberg, Group General Counsel of Vifor Pharma.

Key Points: 
  • We are pleased to have settled all outstanding patent litigations regarding Injectafer, commented Dr. Oliver P. Kronenberg, Group General Counsel of Vifor Pharma.
  • Injectafer is an important treatment option for patients with iron deficiency anemia, said Gretchen Fritz, Chief Legal Officer of American Regent.
  • Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care).
  • Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).

Addex Provides Year End Pipeline Development Update

Retrieved on: 
Wednesday, December 15, 2021
L-DOPA, Therapy, Lists of diseases, PAM, Post-traumatic stress disorder, Protein, Clinical trial, Allosteric regulation, Epilepsy, PTSD, Glutamate receptor, Nasdaq, IND, Neurodegeneration, SIX Swiss Exchange, LR, Janssen Pharmaceuticals, Dyskinesia, American depositary receipt, ADX71149, Drug discovery, CEO, NAM, Patient, Blepharospasm, Glutamate (neurotransmitter), Johnson & Johnson, Glutamic acid, Program, GABAB, Dystonia, Spasms, Pharmaceutical industry

53 LR

Key Points: 
  • 53 LR
    Geneva, Switzerland, 15 December 2021 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today provided an update on progress in its product pipeline.
  • We are also making great progress in our earlier stage pipeline, with three programs on track to enter IND enabling studies in 2022, said Tim Dyer, CEO of Addex.
  • We expect to report top-line data at the end of Q4 2022.
  • Dipraglurant Study 203 for blepharospasm: Enrolment is progressing as planned and we expect top-line data around the end of Q1 2022.

WISeKey celebrates 15th anniversary of partnership with CISCO with 100 million chips delivered so far and announces opening of a second additional sourcing to support growth

Retrieved on: 
Monday, December 13, 2021
Trust anchor, Computer, Big data, Internet, City, Growth, IOT, Artificial intelligence, WIHN, NASDAQ, AI, WKEY, Cisco Systems, SIX Swiss Exchange, CISCO, Semiconductor, Fulcrum, Partnership, Technology, Network equipment, Cryptocurrency, Blockchain

WISeKey is celebrating this year the 15th anniversary of its supply partnership with Cisco.

Key Points: 
  • WISeKey is celebrating this year the 15th anniversary of its supply partnership with Cisco.
  • WISeKey has been a strong partner to Cisco from all aspects: technology, quality and supply flexibility.
  • The relationship started in 2007 and we have since them used more then 100 million WISeKey chips in our product.
  • We value the relationship with the WISeKey executive team, said Marco De Martin, Cisco Global Supplier Management Vice President.